FDA Inspection
Bachem Americas, Inc.Bachem Americas, Inc. – FDA Inspection, May 4, 2026
Record Details
This FDA Inspection record concerns Bachem Americas, Inc., with an inspection on May 4, 2026, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 98d6c6f5-ba42-4eb4-9fa7-a62e51be23f8
Inspection Facts
- Inspection number
- 1315898
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Bachem Americas, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| October 25, 2024 | Not classified | Los Angeles District Office | |
| June 28, 2024 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| February 23, 2022 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| December 13, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 12, 2019 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Bachem Americas, Inc.
- FDA Inspection 1255253 - 2024-10-25
- FDA Inspection 1244716 - 2024-06-28
- FDA Inspection 1163831 - 2022-02-23
- FDA Inspection 1114275 - 2019-12-13
- FDA Inspection 1094231 - 2019-06-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.